Depressive-like behavior induced by tumor necrosis factor-α in mice

Anisman, 2002, Cytokines as a stressor: implications for depressive illness, Int. J. Neuropsychopharmacol., 5, 357, 10.1017/S1461145702003097 Anisman, 2005, Cytokines as a precipitant of depressive illness: animal and human studies, Curr. Pharm. Des., 11, 963, 10.2174/1381612053381701 Bai, 2001, Intra- and interstrain differences in models of “behavioral despair”, Pharmacol. Biochem. Behav., 70, 187, 10.1016/S0091-3057(01)00599-8 Baud, 2001, Signal transduction by tumor necrosis factor and its relatives, Trends Cell Biol., 11, 372, 10.1016/S0962-8924(01)02064-5 Bianchi, 1992, Central effects of tumor necrosis factor alpha and interleukin-1α on nociceptive thresholds and spontaneous locomotor activity, Neurosci. Lett., 148, 76, 10.1016/0304-3940(92)90808-K Bluthe, 2000, Role of interleukin–1beta and tumour necrosis factor-alpha in lipopolysaccharide-induced sickness behavior A study with interleukin-1 type I receptor-deficient mice, Eur. J. Neurosci., 12, 4447 Boka, 1994, Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson’s disease, Neurosci. Lett., 172, 151, 10.1016/0304-3940(94)90684-X Borsini, 1995, Role of the serotonergic system in the forced swimming test, Neurosci. Biobehav. Rev., 19, 377, 10.1016/0149-7634(94)00050-B Brocardo, 2008, Folic acid administration produces an antidepressant-like effect in mice: evidence for the involvement of the serotonergic and noradrenergic systems, Neuropharmacology, 54, 464, 10.1016/j.neuropharm.2007.10.016 Brocardo, 2008, Antidepressant-like effect of folic acid: Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway, Eur. J. Pharmacol., 598, 37, 10.1016/j.ejphar.2008.08.033 Brocardo, 2007, Zinc attenuates malathion-induced depressant-like behavior and confers neuroprotection in the rat brain, Toxicol. Sci., 97, 140, 10.1093/toxsci/kfm024 Capuron, 2002, Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions, Neuropsychopharmacology, 26, 643, 10.1016/S0893-133X(01)00407-9 Cryan, 2003, Withdrawal from chronic amphetamine induces depressive-like behavioral effects in rodents, Biol. Psychiatry, 54, 49, 10.1016/S0006-3223(02)01730-4 Dantzer, 2004, Innate immunity at the forefront of psychoneuroimmunology, Brain Behav. Immun., 18, 1, 10.1016/j.bbi.2003.09.008 Dantzer, 2008, From inflammation to sickness and depression: when the immune system subjugates the brain, Nat. Rev. Neurosci., 9, 46, 10.1038/nrn2297 Dantzer, 2009, Cytokine, sickness behavior and depression, Immunol. Allergy Clin. North Am., 29, 247, 10.1016/j.iac.2009.02.002 Diamond, 2006, Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade, Eur. Neuropsychopharmacol., 16, 481, 10.1016/j.euroneuro.2005.11.011 Dowlati, 2010, A meta-analysis of cytokines in major depression, Biol. Psychiatry, 67, 446, 10.1016/j.biopsych.2009.09.033 Fiore, 1996, Neurobehavioral alterations in developing transgenic mice expressing TNF-α in the brain, Brain Behav. Immun., 10, 126, 10.1006/brbi.1996.0013 Franklin, 1997 Grippo, 2005, Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia, Physiol. Behav, 84, 697, 10.1016/j.physbeh.2005.02.011 Khairova, 2009, A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder, Int. J. Neuropsychopharmacol., 12, 561, 10.1017/S1461145709009924 Kaster, 2005, Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test, Int. J. Neuropsychopharmacol., 8, 601, 10.1017/S1461145705005316 Kaster, 2007, Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of adenosine in the mouse forced swimming test, Eur. J. Pharmacol., 576, 91, 10.1016/j.ejphar.2007.08.026 Kronfol, 2000, Cytokines and the brain: implications for clinical psychiatry, Am. J. Psychiatry, 157, 683, 10.1176/appi.ajp.157.5.683 Kubera, 1995, The effect of chronic treatment with imipramine on the immunoreactivity of animals subjected to a chronic mild stress model of depression, Immunopharmacology, 30, 225, 10.1016/0162-3109(95)00026-P Laursen, 1986, Intracerebroventricular injections in mice. Some methodological refinements, J. Pharmacol. Methods, 16, 355, 10.1016/0160-5402(86)90038-0 Loftisa, 2010, Neuroimmune mechanisms of cytokine-induced depression: current theories and novel treatment strategies, Neurobiol. Dis., 37, 519, 10.1016/j.nbd.2009.11.015 Luo, 2008, Involvement of hippocampal serotonin and neuropeptide Y in depression induced by chronic unpredicted mild stress, Brain Res. Bull., 77, 8, 10.1016/j.brainresbull.2008.05.010 Maes, 2009, The inflammatory & neurodegenerative hypothesis of depression: leads for future research and new drug developments in depression, Metab. Brain Dis., 24, 27, 10.1007/s11011-008-9118-1 Mikova, 2001, Increased serum tumor necrosis factor-α concentrations in major depression and multiple sclerosis, Eur. Neuropsychopharmacol., 11, 203, 10.1016/S0924-977X(01)00081-5 Moreira, 1993, Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation, J. Exp. Med., 177, 1675, 10.1084/jem.177.6.1675 Nadeau, 1999, Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood–brain barrier, Neuroscience, 93, 1449, 10.1016/S0306-4522(99)00225-0 O’Reilly, 2006, Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice, Neuropsychopharmacology, 31, 1919, 10.1038/sj.npp.1300998 O’Sullivan, 2009, Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration, Int. J. Neuropsychopharmacol., 12, 687, 10.1017/S146114570800967X Papanicolaou, 1998, The pathophysiology roles of interleukin-6 in human disease, Ann. Intern. Med., 128, 127, 10.7326/0003-4819-128-2-199801150-00009 Parnet, 1994, Expression of type I and type II interleukin-1 receptors in mouse brain, Mol. Brain Res., 27, 63, 10.1016/0169-328X(94)90185-6 Porsolt, 1997, Behavioral despair in mice: a primary screening test for antidepressants, Arch. Int. Pharmacodyn. Ther., 229, 327 Posser, 2009, Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system, Eur. J. Pharmacol., 602, 85, 10.1016/j.ejphar.2008.10.055 Qin, 2007, Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration, Glia, 55, 453, 10.1002/glia.20467 Raje, 2002, Thalidomide and immunomodulatory drugs as cancer therapy, Curr. Opin. Oncol., 14, 635, 10.1097/00001622-200211000-00008 Reynolds, 2004, Brain-derived tumor necrosis factor-alpha and its involvement in noradrenergic neuron functioning involved in the mechanism of action of an antidepressant, J. Pharmacol. Exp. Ther, 310, 1216, 10.1124/jpet.104.067835 Reynolds, 2005, An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-α production culminating in increases in noradrenergic neurotransmission, Neuroscience, 133, 519, 10.1016/j.neuroscience.2005.02.023 Riches, 1998, Cooperative signaling by tumor necrosis factor receptors CD120a (p55) and CD120b (p75) in the expression of nitric oxide and inducible nitric oxide synthase by mouse macrophages, J. Biol. Chem., 273, 22800, 10.1074/jbc.273.35.22800 Rothe, 1993, Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes, Nature, 364, 798, 10.1038/364798a0 Roumestan, 2007, Anti-inflammatory properties of desipramine and fluoxetine, Respir. Res., 8, 35, 10.1186/1465-9921-8-35 Sampaio, 1991, Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes, J. Exp. Med., 173, 699, 10.1084/jem.173.3.699 Schiepers, 2005, Cytokines and major depression, Prog. Neuropsychopharmacol. Biol. Psychiatry, 29, 201, 10.1016/j.pnpbp.2004.11.003 Schobitz, 1993, Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain, Eur. J. Neurosci., 5, 1426, 10.1111/j.1460-9568.1993.tb00210.x Simen, 2006, TNF-α signaling in depression and anxiety: behavioral consequences of individual receptor targeting, Biol. Psychiatry, 59, 775, 10.1016/j.biopsych.2005.10.013 Song, 1994, An acute phase response in the olfactory bulbectomised rat: effect of sertraline treatment, Med. Sci. Res., 22, 313 Steru, 1985, The tail suspension test: a new method for screening antidepressants in mice, Psychopharmacology, 85, 367, 10.1007/BF00428203 Szelenyi, 2007, The catecholamine cytokine balance: interaction between the brain and the immune system, Ann. N.Y. Acad. Sci., 1113, 311, 10.1196/annals.1391.026 Tartaglia, 1992, Two TNF receptors, Immun. Today, 13, 151, 10.1016/0167-5699(92)90116-O Tartaglia, 1993, A novel domain within the 55 kD TNF receptor signals cell death, Cell, 74, 845, 10.1016/0092-8674(93)90464-2 Tchélingérian, 1994, TNF-α gene expression is induced in neurons after a hippocampal lesion, NeuroReport, 5, 585, 10.1097/00001756-199401000-00013 Tchélingérian, 1996, Identification and topography of neuronal cell populations expressing TNF-α and IL-1α. in response to hippocampal lesion, J. Neurosci. Res., 43, 99, 10.1002/jnr.490430113 Tsagarakis, 1989, Interleukin-1 directly stimulates the release of corticotrophin-releasing factor from rat hypothalamus, Neuroendocrinology, 49, 98, 10.1159/000125096 Tuglu, 2003, Increased serum tumor necrosis factor-α levels and treatment response in major depressive disorder, Psychopharmacology, 170, 429, 10.1007/s00213-003-1566-z Willner, 1991, Animal models as simulations of depression, Trends Pharmacol. Sci., 12, 131, 10.1016/0165-6147(91)90529-2 Xia, 1996, Tricyclic antidepressants inhibit IL-6, IL-1β and TNF-α release in human blood monocytes and IL-2 and interferon-gamma in T cells, Immunopharmacology, 34, 27, 10.1016/0162-3109(96)00111-7 Yamada, 2000, Neurobehavioral alterations in mice with a targeted deletion of the tumor necrosis factor-α gene: implications for emotional behavior, J. Neuroimmunol., 111, 131, 10.1016/S0165-5728(00)00375-1 Yirmiya, 2000, Illness cytokines and depression, Ann. N.Y. Acad. Sci., 917, 478, 10.1111/j.1749-6632.2000.tb05412.x Yirmiya, 2001, Effects of antidepressant drugs on the behavioral and physiological responses to lipopolysaccharide (LPS) in rodents, Neuropsychopharmacology, 24, 531, 10.1016/S0893-133X(00)00226-8 Zhu, 2006, The proinflammatory cytokines interleukin-1β and tumor necrosis factor-α activate serotonin transporters, Neuropsychopharmacology, 31, 2121, 10.1038/sj.npp.1301029